Bristol-Myers Squibb buy Truist Financial Co.
Start price
15.09.23
/
50%
€55.60
Target price
15.09.24
€78.67
Performance (%)
-20.88%
End price
16.09.24
€43.99
Summary
This prediction ended on 16.09.24 with a price of €43.99. The price of Bristol-Myers Squibb has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.88%. A total of €2.19 was paid as dividends for this prediction. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 3.090% | 3.090% | -11.325% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $84.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.56
08.01.25
08.01.25
€63.06
08.01.26
08.01.26
-13.17%
09.01.26
09.01.26
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.50
06.10.23
06.10.23
€79.27
06.10.24
06.10.24
-8.08%
07.10.24
07.10.24